EA201000039A1 - Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль - Google Patents

Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль

Info

Publication number
EA201000039A1
EA201000039A1 EA201000039A EA201000039A EA201000039A1 EA 201000039 A1 EA201000039 A1 EA 201000039A1 EA 201000039 A EA201000039 A EA 201000039A EA 201000039 A EA201000039 A EA 201000039A EA 201000039 A1 EA201000039 A1 EA 201000039A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
pharmaceutically
adaptable
salt
composition including
Prior art date
Application number
EA201000039A
Other languages
English (en)
Other versions
EA020333B1 (ru
Inventor
Райнер Аллес
Дуня Коченройтер
Гертрауд Кёлльнер
Катрин Римкус
Франк Мускулус
Зандра Брюк
Яна Пэтц
Original Assignee
Рациофарм Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рациофарм Гмбх filed Critical Рациофарм Гмбх
Publication of EA201000039A1 publication Critical patent/EA201000039A1/ru
Publication of EA020333B1 publication Critical patent/EA020333B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

В заявке описаны фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль, и способ получения указанной фармацевтической композиции.
EA201000039A 2007-07-24 2008-07-23 Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль EA020333B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07014500A EP2018850A1 (en) 2007-07-24 2007-07-24 Pharmaceutical composition comprising solifenacin or a pharmaceutically acceptable salt thereof
PCT/EP2008/006047 WO2009012987A1 (en) 2007-07-24 2008-07-23 Pharmaceutical composition comprising solifenacin or a pharmaceutically acceptable salt thereof

Publications (2)

Publication Number Publication Date
EA201000039A1 true EA201000039A1 (ru) 2010-08-30
EA020333B1 EA020333B1 (ru) 2014-10-30

Family

ID=38837818

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000039A EA020333B1 (ru) 2007-07-24 2008-07-23 Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль

Country Status (5)

Country Link
EP (2) EP2018850A1 (ru)
CA (1) CA2693179A1 (ru)
EA (1) EA020333B1 (ru)
ES (1) ES2740674T3 (ru)
WO (1) WO2009012987A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2394648T1 (sl) * 2009-02-04 2017-02-28 Astellas Pharma Inc. Farmacevtski sestavek za oralno dajanje
DK2400954T3 (en) 2009-02-27 2017-01-16 Krka D D Novo Mesto Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts
EP2415472A4 (en) * 2009-03-30 2013-02-20 Astellas Pharma Inc SOLID PHARMACEUTICAL COMPOSITION WITH SOLUBENACIN AMORPHIC BODY
WO2011137877A2 (en) * 2010-05-07 2011-11-10 Zentiva K.S. A pharmaceutical composition containing solifenacin and a method of its manufacture
EP2500013B1 (en) 2011-03-15 2019-10-02 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising solifenacin
EP2778167A1 (en) 2013-03-11 2014-09-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt
KR20150092385A (ko) 2014-02-03 2015-08-13 씨제이헬스케어 주식회사 솔리페나신을 포함하는 안정한 제제 및 이의 제조방법
WO2015170237A1 (en) * 2014-05-05 2015-11-12 Torrent Pharmaceuticals Limited Stable solifenacin composition
KR101977890B1 (ko) * 2018-05-08 2019-05-13 씨제이헬스케어 주식회사 솔리페나신을 포함하는 안정한 제제 및 이의 제조방법
WO2022117594A1 (en) 2020-12-01 2022-06-09 Adamed Pharma S.A. Orally-administered preparation containing solifenacin and tamsulosin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
KR20070010132A (ko) * 2004-03-25 2007-01-22 아스텔라스세이야쿠 가부시키가이샤 솔리페나신 또는 그의 염의 고형 제제용 조성물
CA2591761A1 (en) * 2004-12-27 2006-07-06 Astellas Pharma Inc. Stable particulate pharmaceutical composition of solifenacin or salt thereof

Also Published As

Publication number Publication date
EP2018850A1 (en) 2009-01-28
EP2178507A1 (en) 2010-04-28
EP2178507B1 (en) 2019-05-15
WO2009012987A1 (en) 2009-01-29
EA020333B1 (ru) 2014-10-30
CA2693179A1 (en) 2009-01-29
ES2740674T3 (es) 2020-02-06

Similar Documents

Publication Publication Date Title
NL301261I2 (nl) Gefapixant, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
NO2023047I1 (no) Cedazuridine, or a pharmaceutically acceptable salt thereof
NO2020038I1 (no) Ozanimod, or a pharmaceutically acceptable salt thereof, including the hydrochloride salt
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
NL301150I2 (nl) setmelanotide, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NL301049I1 (nl) Crisaborale, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NL301202I1 (nl) Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline
NL301037I2 (nl) Solriamfetol of een farmaceutisch aanvaardbaar zout daarvan, bij voorkeur het hydrochloridezout daarvan
NL301042I1 (nl) Trifaroteen, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NO2018028I1 (no) Alogliptin i kombinasjon med plaglitazon, hver eventuelt i form av et farmasøytisk akseptabelt salt derav
NO2016016I2 (no) Lesinurad, eller et farmasøytisk akseptabelt salt derav
NL300703I2 (nl) Simeprevir, of een farmaceutisch aanvaardbaar zout daarvan, waaronder simeprevirnatrium.
BRPI0810646A2 (pt) " compostos farmacêuticos ".
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
BRPI0910734A2 (pt) composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo.
CY1111729T1 (el) Υπογλωσσιο επικαλυμμενο δισκιο
ATE447568T1 (de) Neue pyrinderivate
DK2051975T3 (da) Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
BRPI0912539A2 (pt) composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
NL1028193A1 (nl) Farmaceutisch werkzame verbindingen.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
FR2932486B1 (fr) Procede de preparation d'un polyamideimide, polyamideimide et composition comprenant ce polyamideimide.
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
RS54158B1 (en) AMILOID BINDING AGENTS

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU